Skip to main content

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors.

Publication ,  Journal Article
Crosby, EJ; Lyerly, HK; Hartman, ZC
Published in: Oncotarget
January 5, 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Oncotarget

DOI

EISSN

1949-2553

Publication Date

January 5, 2021

Volume

12

Issue

1

Start / End Page

1 / 3

Location

United States

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Crosby, E. J., Lyerly, H. K., & Hartman, Z. C. (2021). Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors. Oncotarget, 12(1), 1–3. https://doi.org/10.18632/oncotarget.27861
Crosby, Erika J., H Kim Lyerly, and Zachary C. Hartman. “Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors.Oncotarget 12, no. 1 (January 5, 2021): 1–3. https://doi.org/10.18632/oncotarget.27861.
Crosby, Erika J., et al. “Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors.Oncotarget, vol. 12, no. 1, Jan. 2021, pp. 1–3. Pubmed, doi:10.18632/oncotarget.27861.

Published In

Oncotarget

DOI

EISSN

1949-2553

Publication Date

January 5, 2021

Volume

12

Issue

1

Start / End Page

1 / 3

Location

United States

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis